PharmaRadar360
PharmaRadar360
Intelligence Layer
🇬🇧·1d agoResearch

Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications

Publisher

N
Nature Gene Therapy

UK

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on nature.com

Leave the platform to read the original full article on the publisher site.

Source: Nature Gene Therapy

Scope: Research

Open original article
Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications | PharmaRadar360